e-Therapeutics PLC | Income Statement
Fiscal year is February-January. All values GBP Thousands.
2014
2015
2016
2017
2018
2019
Cost of Goods Sold (COGS) incl. D&A
83.00
72.00
73.00
56.00
62.00
54
Gross Income
83.00
72.00
73.00
56.00
62.00
10
SG&A Expense
6,636.00
10,103.00
11,482.00
13,469.00
6,699.00
5,086
EBIT
6,719.00
10,175.00
11,555.00
13,525.00
6,761.00
5,096
Unusual Expense
-
-
-
2,805.00
10.00
19
Non Operating Income/Expense
-
-
-
-
3.00
1
Pretax Income
6,102.00
9,818.00
11,284.00
16,198.00
6,719.00
5,085
Income Tax
1,063.00
2,041.00
2,464.00
3,073.00
1,360.00
1,086
Consolidated Net Income
5,039.00
7,777.00
8,820.00
13,125.00
5,359.00
3,999
Net Income
5,039.00
7,777.00
8,820.00
13,125.00
5,359.00
3,999
Net Income After Extraordinaries
5,039.00
7,777.00
8,820.00
13,125.00
5,359.00
3,999
Net Income Available to Common
5,039.00
7,777.00
8,820.00
13,125.00
5,359.00
3,999
EPS (Basic)
0.02
0.03
0.03
0.05
0.02
0.01
Basic Shares Outstanding
254,398.20
264,147.90
264,419.50
267,062.30
268,457.10
268,581.10
EPS (Diluted)
0.02
0.03
0.03
0.05
0.02
0.01
Diluted Shares Outstanding
261,082.20
277,085.40
276,538.30
282,663.30
268,457.10
268,581.10
EBITDA
6,636.00
10,103.00
11,482.00
13,469.00
6,699.00
5,042
Non-Operating Interest Income
617.00
357.00
271.00
132.00
49.00
29
About e-Therapeutics
View Profile
